Tag Archive for: Optimum

Radio what’s new? Tuning in to turning cancer cells off

Tuning in to the field of targeted cancer medicine through molecular radiotherapy or targeted radionuclides.

Sanofi offers to acquire Kiadis for €308 million

Congratulations to Kiadis Pharma on recently announcing that it is being acquired by Sanofi in a deal valued at approximately €308m ($359m), a 272% premium over last week’s closing price, one of the largest premiums in European biotech. After the discontinuation of its lead product candidate and subsequent reorganization in 2019, Kiadis started 2020 as an entirely new company […]

Covid-19: The Industry Response – How Are we Doing?

Chair: Clive Cookson, Science Editor, Financial Times Sean Marett, Chief Business and Chief Commercial Officer, BioNTech Professor James Logan, Head of Department of Disease Control, London School of Hygiene and Tropical Medicine Kate Bingham, Chair of UK Vaccine Taskforce & Managing Partner of SV Health Investors Rajeev Venkayya, MD, President Global Vaccine Business Unit, Takeda […]

Desperately Seeking Serendipity – Engaging in the new virtual

This year, in collaboration with Dechert, we held a virtual version of our leading Annual Healthcare Investor Conference on the 8th of October. The 12th event discussed how life sciences innovation is driving change – from the myriad international efforts against Covid-19 to how we communicate with the investment community. The virtue of virtual was […]